← Back to Search

Group Interventions for Breast Cancer Survivors

N/A
Waitlist Available
Led By Wendy Lichtenthal, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 or older
History of non-metastatic breast cancer (DCIS or Stage I, II, or III) as recorded in the medical record at MSKCC by self-report, or by outside correspondence, including a study checklist signed by a physician for patients outside of MSKCC
Must not have
Evidence of or treatment metastatic disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is comparing the benefits of two types of groups for breast cancer survivors: a Meaning-Centered Group and a Discussion Group.

Who is the study for?
This trial is for breast cancer survivors who have completed treatment, are over 18 years old, and feel distressed related to their cancer or survivorship. They must be stable on any mood-related medications and have access to a phone and internet. Those with metastatic disease or significant psychiatric issues that prevent informed consent are excluded.
What is being tested?
The study compares two group interventions for emotional support: a 'Meaning-Centered Group' designed to help find purpose post-treatment, and a 'Discussion Group' for general survivor support. The effectiveness of conducting these groups virtually is also being tested.
What are the potential side effects?
Since the interventions involve psychological support rather than medication, traditional side effects aren't expected. Participants may experience emotional discomfort when discussing personal experiences related to their cancer journey.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I had breast cancer before, but it did not spread to other parts of my body.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My cancer has spread to other parts of my body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Meaning-Centered Group for Breast Cancer Survivors (MCG-BCS)Experimental Treatment1 Intervention
Group II: Discussion Group (DG)Active Control1 Intervention

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,969 Previous Clinical Trials
597,147 Total Patients Enrolled
207 Trials studying Breast Cancer
82,323 Patients Enrolled for Breast Cancer
American Cancer Society, Inc.OTHER
231 Previous Clinical Trials
109,446 Total Patients Enrolled
32 Trials studying Breast Cancer
8,472 Patients Enrolled for Breast Cancer
Wendy Lichtenthal, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
7 Previous Clinical Trials
1,159 Total Patients Enrolled
1 Trials studying Breast Cancer
252 Patients Enrolled for Breast Cancer

Media Library

Manualized Group Intervention Clinical Trial Eligibility Overview. Trial Name: NCT01775085 — N/A
Breast Cancer Research Study Groups: Meaning-Centered Group for Breast Cancer Survivors (MCG-BCS), Discussion Group (DG)
Breast Cancer Clinical Trial 2023: Manualized Group Intervention Highlights & Side Effects. Trial Name: NCT01775085 — N/A
Manualized Group Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT01775085 — N/A
~1 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top